Report Summary
Eternity Insights has published a new study on Global Fexofenadine Market focusing on key segments as by Type (Purity:98%, Purity:>98%, Other), by Application (Hay Fever Treatment, Urticaria Treatment, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Fexofenadine Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Fexofenadine Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Fexofenadine Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Fexofenadine Market Segmentation:
Fexofenadine Market, By Type
- Purity:98%
- Purity:>98%
- Other
Fexofenadine Market, By Application
- Hay Fever Treatment
- Urticaria Treatment
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Fexofenadine market in terms of demand generation. The Fexofenadine market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Fexofenadine market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Fexofenadine Market Taxonomy:
To learn more about this report
Global Fexofenadine Market Competitive Landscape
The global Fexofenadine market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Viruj Pharma
- Cemex Pharma
- Smaart Pharmaceutticals
- Titan Pharma
- AFCL
- Synkromax
- Farmhispania
- Gen Pharma
- Admiron Life Sciences Private Limited
- JRC
- Archerchem
- Sibram
- Sumitomo Chemical
- Panchsheel
- CAMEO HEALTH CARE
- CEPiA-Sanofi
- Va Sudha Pharma Chem Limited
- VPL Chemicals Pvt Ltd
- Zhejiang Excel Pharmaceutical Co ltd
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Purity:98%, Purity:>98%, Other |
| By Application Outlook |
Hay Fever Treatment, Urticaria Treatment, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Viruj Pharma, Cemex Pharma, Smaart Pharmaceutticals, Titan Pharma, AFCL, Synkromax, Farmhispania, Gen Pharma, Admiron Life Sciences Private Limited, JRC, Archerchem, Sibram, Sumitomo Chemical, Panchsheel, CAMEO HEALTH CARE, CEPiA-Sanofi, Va Sudha Pharma Chem Limited, VPL Chemicals Pvt Ltd, Zhejiang Excel Pharmaceutical Co ltd |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Fexofenadine Market Overview
1.1 Fexofenadine Product Overview
1.2 Fexofenadine Market Segment by Type
1.2.1 Purity:98%
1.2.2 Purity:>98%
1.3 Global Fexofenadine Market Size by Type
1.3.1 Global Fexofenadine Sales and Growth by Type
1.3.2 Global Fexofenadine Sales and Market Share by Type (2013-2018)
1.3.3 Global Fexofenadine Revenue and Market Share by Type (2013-2018)
1.3.4 Global Fexofenadine Price by Type (2013-2018)
2 Global Fexofenadine Market Competition by Company
2.1 Global Fexofenadine Sales and Market Share by Company (2013-2018)
2.2 Global Fexofenadine Revenue and Share by Company (2013-2018)
2.3 Global Fexofenadine Price by Company (2013-2018)
2.4 Global Top Players Fexofenadine Manufacturing Base Distribution, Sales Area, Product Types
2.5 Fexofenadine Market Competitive Situation and Trends
2.5.1 Fexofenadine Market Concentration Rate
2.5.2 Global Fexofenadine Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Fexofenadine Company Profiles and Sales Data
3.1 Viruj Pharma
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Fexofenadine Product Category, Application and Specification
3.1.3 Viruj Pharma Fexofenadine Sales, Revenue, Price and Gross Margin(2013-2018)
3.1.4 Main Business Overview
3.2 Cemex Pharma
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Fexofenadine Product Category, Application and Specification
3.2.3 Cemex Pharma Fexofenadine Sales, Revenue, Price and Gross Margin(2013-2018)
3.2.4 Main Business Overview
3.3 Smaart Pharmaceutticals
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Fexofenadine Product Category, Application and Specification
3.3.3 Smaart Pharmaceutticals Fexofenadine Sales, Revenue, Price and Gross Margin(2013-2018)
3.3.4 Main Business Overview
3.4 Titan Pharma
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Fexofenadine Product Category, Application and Specification
3.4.3 Titan Pharma Fexofenadine Sales, Revenue, Price and Gross Margin(2013-2018)
3.4.4 Main Business Overview
3.5 AFCL
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Fexofenadine Product Category, Application and Specification
3.5.3 AFCL Fexofenadine Sales, Revenue, Price and Gross Margin(2013-2018)
3.5.4 Main Business Overview
3.6 Synkromax
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Fexofenadine Product Category, Application and Specification
3.6.3 Synkromax Fexofenadine Sales, Revenue, Price and Gross Margin(2013-2018)
3.6.4 Main Business Overview
3.7 Farmhispania
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Fexofenadine Product Category, Application and Specification
3.7.3 Farmhispania Fexofenadine Sales, Revenue, Price and Gross Margin(2013-2018)
3.7.4 Main Business Overview
3.8 Gen Pharma
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Fexofenadine Product Category, Application and Specification
3.8.3 Gen Pharma Fexofenadine Sales, Revenue, Price and Gross Margin(2013-2018)
3.8.4 Main Business Overview
3.9 Admiron Life Sciences Private Limited
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Fexofenadine Product Category, Application and Specification
3.9.3 Admiron Life Sciences Private Limited Fexofenadine Sales, Revenue, Price and Gross Margin(2013-2018)
3.9.4 Main Business Overview
3.10 JRC
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Fexofenadine Product Category, Application and Specification
3.10.3 JRC Fexofenadine Sales, Revenue, Price and Gross Margin(2013-2018)
3.10.4 Main Business Overview
3.11 Archerchem
3.12 Sibram
3.13 Sumitomo Chemical
3.14 Panchsheel
3.15 CAMEO HEALTH CARE
3.16 CEPiA-Sanofi
3.17 Va Sudha Pharma Chem Limited
3.18 VPL Chemicals Pvt Ltd
3.19 Zhejiang Excel Pharmaceutical Co ltd
4 Fexofenadine Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Fexofenadine Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Fexofenadine Sales and Revenue by Regions
4.2.1 Global Fexofenadine Sales and Market Share by Regions (2013-2018)
4.2.2 Global Fexofenadine Revenue and Market Share by Regions (2013-2018)
4.2.3 Global Fexofenadine Sales, Revenue, Price and Gross Margin (2013-2018)
4.3 North America Fexofenadine Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Fexofenadine Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Fexofenadine Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Fexofenadine Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Fexofenadine Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Fexofenadine Application/End Users
5.1 Fexofenadine Segment by Application
5.1.1 Hay Fever Treatment
5.1.2 Urticaria Treatment
5.2 Global Fexofenadine Product Segment by Application
5.2.1 Global Fexofenadine Sales by Application
5.2.2 Global Fexofenadine Sales and Market Share by Application (2013-2018)
6 Global Fexofenadine Market Forecast
6.1 Global Fexofenadine Sales, Revenue Forecast (2018-2025)
6.1.1 Global Fexofenadine Sales and Growth Rate Forecast (2018-2025)
6.1.1 Global Fexofenadine Revenue and Growth Rate Forecast (2018-2025)
6.2 Global Fexofenadine Forecast by Regions
6.2.1 North America Fexofenadine Sales and Revenue Forecast (2018-2025)
6.2.2 Europe Fexofenadine Sales and Revenue Forecast (2018-2025)
6.2.3 Asia-Pacific Fexofenadine Sales and Revenue Forecast (2018-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Fexofenadine Sales and Revenue Forecast (2018-2025)
6.2.5 Middle East and Africa Fexofenadine Sales and Revenue Forecast (2018-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Fexofenadine Forecast by Type
6.3.1 Global Fexofenadine Sales and Revenue Forecast by Type (2018-2025)
6.3.2 Purity:98% Gowth Forecast
6.3.3 Purity:>98% Gowth Forecast
6.4 Fexofenadine Forecast by Application
6.4.1 Global Fexofenadine Sales Forecast by Application (2018-2025)
6.4.2 Global Fexofenadine Forecast in Hay Fever Treatment
6.4.3 Global Fexofenadine Forecast in Urticaria Treatment
7 Fexofenadine Upstream Raw Materials
7.1 Fexofenadine Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Fexofenadine Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
